Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain
Clinical trial NCT06897917 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06897917
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.